MAJOR CONTRIBUTORS TO ILIAC STENT MARKET GROWTH AND INNOVATION

Major Contributors to Iliac Stent Market Growth and Innovation

Major Contributors to Iliac Stent Market Growth and Innovation

Blog Article

The global iliac stent market was valued at USD 1,047.21 million in 2023 and is projected to expand from USD 1,101.56 million in 2024 to USD 1,708.54 million by 2032, exhibiting a compound annual growth rate (CAGR) of 5.6% during the forecast period. This growth is fueled by the increasing prevalence of peripheral artery disease (PAD), technological innovations in vascular stenting, and a growing preference for minimally invasive procedures.

Iliac stents are small, mesh-like medical devices used to open narrowed or blocked iliac arteries, which supply blood to the lower limbs and pelvis. With aging populations, a sedentary lifestyle, rising diabetes cases, and hypertension becoming more prevalent globally, the demand for endovascular interventions like iliac stenting is on a consistent rise. These stents have revolutionized the treatment landscape by providing durable, safe, and efficient alternatives to open surgeries.

Key Market Growth Drivers

  1. Rising Incidence of Peripheral Artery Disease (PAD)
    PAD affects millions globally, particularly the elderly and individuals with cardiovascular risk factors like diabetes and smoking. Iliac artery stenosis, a form of PAD, is commonly treated with stents to restore adequate blood flow. The growing burden of PAD is directly driving the demand for iliac stents.

  2. Preference for Minimally Invasive Procedures
    Modern iliac stenting techniques allow for faster recovery, reduced hospital stays, and lower complication rates compared to traditional open vascular surgeries. As patients and providers increasingly seek less invasive treatment options, iliac stents are becoming the go-to solution for arterial blockages.

  3. Technological Advancements in Stent Design
    Innovations such as self-expanding nitinol stents, drug-eluting stents, and biocompatible coatings are enhancing the effectiveness and longevity of iliac stent procedures. These next-generation stents offer improved radial strength, flexibility, and resistance to restenosis.

  4. Expanding Geriatric Population
    With global life expectancy rising, there is a substantial increase in age-related vascular disorders. The elderly are particularly susceptible to atherosclerosis and chronic limb ischemia, boosting the demand for endovascular stenting solutions like iliac stents.

  5. Favorable Reimbursement and Healthcare Infrastructure
    In developed regions such as North America and Europe, healthcare systems offer substantial reimbursement for vascular procedures. This encourages hospitals and clinics to adopt stenting as a preferred treatment option for iliac artery disease.

Market Challenges

While the iliac stent market shows strong potential, several challenges may limit its growth:

  • High Cost of Stent Procedures
    Iliac stenting, especially with advanced devices like drug-eluting stents, can be expensive. High costs and inconsistent insurance coverage in emerging markets may limit access for lower-income populations.

  • Restenosis and Complications
    Despite innovations, there remains a risk of restenosis (re-narrowing of the artery) and stent thrombosis. Ongoing monitoring and sometimes additional interventions are necessary, which can deter patients.

  • Skilled Workforce Shortage in Emerging Economies
    The successful deployment of iliac stents requires experienced vascular surgeons or interventional radiologists. A shortage of trained specialists in several regions can slow down market adoption.

  • Regulatory Hurdles and Product Recalls
    Regulatory approvals for new stent designs can be lengthy and complex. In some cases, product recalls due to performance issues or biocompatibility concerns can also negatively impact consumer confidence and market growth.

Market Segmentation

Iliac Stent Market, Type Outlook (Revenue - USD Million, 2019-2032)
  • Self-expandable Stents
  • Balloon-expandable Stents
  • Others
Iliac Stent Market, Artery Lesions Outlook (Revenue - USD Million, 2019-2032)
  • Common Iliac Artery Lesions
  • Severe Calcified Lesions
  • Complete Obstructive Lesions
Iliac Stent Market, End-Use Outlook (Revenue - USD Million, 2019-2032)
  • Hospitals
  • Ambulatory surgical centers
  • Others
Iliac Stent Market, Regional Outlook (Revenue - USD Million, 2019-2032)
  • North America
    • Type Outlook
      • Self-expandable Stents
      • Balloon-expandable Stents
      • Others
    • Artery Lesions Outlook
      • Common Iliac Artery Lesions
      • Severe Calcified Lesions
      • Complete Obstructive Lesions
    • End-Use Outlook
      • Hospitals
      • Ambulatory surgical centers
      • Others
  • Europe
    • Type Outlook
      • Self-expandable Stents
      • Balloon-expandable Stents
      • Others
    • Artery Lesions Outlook
      • Common Iliac Artery Lesions
      • Severe Calcified Lesions
      • Complete Obstructive Lesions
    • End-Use Outlook
      • Hospitals
      • Ambulatory surgical centers
      • Others

Key Companies in the Iliac Stent Market

Leading medical device manufacturers are competing to offer innovative stent designs, expand geographic presence, and form strategic alliances to gain a competitive edge. Key players include:

  • Medtronic plc
    A global leader in cardiovascular solutions, Medtronic offers iliac stents as part of its endovascular therapy portfolio, with products like the Complete SE Vascular Stent System.

  • Boston Scientific Corporation
    Known for its Express LD Iliac Premounted Stent System, Boston Scientific provides high-performance stents with optimal deliverability and radial strength.

  • Cook Medical
    Cook’s Zilver and Flexor stent lines are widely used in peripheral and iliac arterial procedures, offering minimally invasive and flexible treatment options.

  • Abbott Laboratories
    Abbott develops drug-eluting and balloon-expandable stents for peripheral vascular use, offering innovation and high reliability.

  • Terumo Corporation
    A leading Japanese medical device company with a growing footprint in peripheral vascular interventions, including iliac stent solutions.

Other significant players include Bentley InnoMed GmbH, Biotronik, B. Braun Melsungen AG, and Cordis (a Cardinal Health company), each contributing to innovation and market development in iliac stenting.

Explore More: https://www.polarismarketresearch.com/industry-analysis/iliac-stent-market 

Conclusion

The iliac stent market is on a strong growth trajectory, poised to surpass USD 1.7 billion by 2032. As the burden of peripheral artery disease rises and healthcare shifts toward less invasive treatment modalities, iliac stents will continue to gain popularity among physicians and patients. Continued innovation in stent materials, drug-elution technology, and deployment systems — alongside broader global healthcare access — will be critical to sustaining this momentum.

Companies that prioritize clinical outcomes, affordability, and regulatory excellence will be best positioned to lead in this dynamic and essential sector of vascular health.

More Trending Latest Reports By Polaris Market Research: Cosmetic Surgery Market Hemodialysis and Peritoneal Dialysis Market Hospital Supplies Market India Diagnostic Services Market Medical Device Outsourcing Market Irritable Bowel Syndrome (IBS) Treatment Market Car T Cell Therapy Market Migraine Drugs Market Nephrology and Urology Devices Market Medical Waste Container Market Dental Implants Market eClinical Solutions Market Animal Genetics Market Targeted DNA RNA Sequencing Market Blood Glucose Monitoring Device Market Non-Invasive Prenatal Testing (NIPT) Market Medical Device Cleaning Market Targeted Protein Degradation Market Cancer or Tumor Profiling Market Prefilled Syringes Market Canine Orthopedics Market Speaking Valve Market Blood Warmers Market Non-alcoholic Steatohepatitis Treatment Market Paracetamol IV Market Personalized Medicine Biomarkers Market

Report this page